Endothelin receptors in morphine withdrawal

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61K 31/485 (2006.01)

Patent

CA 2641386

The present invention relates to compositions and methods for managing opioid tolerance and reducing opioid withdrawal. More specifically, the present invention provides for endothelin, endothelin receptors, and endothelin receptor antagonists and agonists as a means for managing G-protein activity in the context of opioid tolerance and withdrawal.

La présente invention porte sur des compositions et des méthodes permettant de gérer la tolérance aux opiacés et de réduire le sevrage des opiacés. Cette invention porte de manière plus spécifique sur l'endothéline, des récepteurs de l'endothéline et des antagonistes et agonistes des récepteurs de l'endothéine comme moyen de gérer l'activité de la protéine G dans le contexte de la tolérance aux opiacés et du sevrage des opiacés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Endothelin receptors in morphine withdrawal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin receptors in morphine withdrawal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin receptors in morphine withdrawal will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1834457

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.